Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; Implications for regenerative medicine

Angiogenesis

Volumn 16, Issue 3, 2013, Pages 595-607

  Cipriani, Paola ^a   Marrelli, Alessandra ^a   Benedetto, Paola Di ^a   Liakouli, Vasiliki ^a   Carubbi, Francesco ^a   Ruscitti, Piero ^a   Alvaro, Saverio ^a   Pantano, Ilenia ^a   Campese, Antonio Francesco ^b   Grazioli, Paola ^b   Screpanti, Isabella ^b   Giacomelli, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angiogenesis; Mesenchymal stem cells; Pericytes; Systemic sclerosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; PLATELET DERIVED GROWTH FACTOR BB; RGS PROTEIN; RGS5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSGELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL; MYOFIBROBLAST; PERICYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC SCLEROSIS; UPREGULATION; WESTERN BLOTTING;

ACTINS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MESENCHYMAL STROMAL CELLS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-SIS; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879240261     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9338-9     Document Type: Article

References (52)

1. LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22:675-694
2. Kahaleh MB (2004) Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 22(3 Suppl 33): S19-S23
3. Fleming JN, Nash RA, Mahoney WM Jr, Schwartz SM (2009) Is scleroderma a vasculopathy? Curr Rheumatol Rep 11:103-110
4. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, et al. (2007) Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells:new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 56:1994-2004
5. Manetti M, Ibba-Manneschi L, Liakouli V, Guiducci S, Milia AF, et al. (2010) The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 69:598-605
6. Cipriani P, Franca Milia A, Liakouli V, Pacini A, Manetti M, et al. (2006) Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications. Arthritis Rheum 54:3022-3033
7. Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R (2011) Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev 10:641-646
8. Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, et al. (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10:590-594
9. Murakami M, Simons M (2009) Regulation of vascular integrity. J Mol Med 87:571-582
10. Simons M (2005) Angiogenesis: where do we stand now? Circulation 111:1556-1566
11. Hirschi KK, D'Amore PA (1996) Pericytes in the microvasculature. Cardiovasc Res 32:687-698
12. Antonelli-Orlidge A, Smith SR, D'Amore PA (1989) Influence of pericytes on capillary endothelial cell growth. Am Rev Respir Dis 140:1129-1131
13. Gerhardt H, Semb H (2008) Pericytes: gatekeepers in tumour cell metastasis? J Mol Med 86:135-144
14. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512-523
15. Takakura N (2011) Role of intimate interactions between endothelial cells and the surrounding accessory cells in the maturation of blood vessels. J Thromb Haemost 9:144-150
16. Hirschi KK, Rohovsky SA, D'Amore PA (1998) PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805-814
17. Walshe TE (2010) TGF-beta and microvessel homeostasis. Microvasc Res 80:166-173
18. Darland DC, D'Amore PA (2001) TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 4:11-20
19. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 11:301-313
20. da Silva Meirelles L, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287-2299
21. Cai X, Lin Y, Friedrich CC, Neville C, Pomerantseva I, et al. (2009) Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev 5:437-445
22. Bryan BA, D'Amore PA (2008) Pericyte isolation and use in endothelial/pericyte coculture models. Methods Enzymol 443:315-331
23. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 19:324-336
24. Tormin A, Li O, Brune JC, Walsh S, Schütz B, et al. (2011) CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 12:5067-5077
25. da Silva Meirelles L, Sand TT, Harman RJ, Lennon DP, Caplan AI (2009) MSC frequency correlates with blood vessel in equine adipose tissue. Tissue Eng Part A 15:221-229
26. Toma JG, Akhavan M, Fernandes KJ, Barnabé-Heider F, Sadikot A, et al. (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778-784
27. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97:13625-13630
28. Díaz-Flores L Jr, Madrid JF, Gutiérrez R, Varela H, Valladares F (2006) Adult stem and transit-amplifying cell location. Histol Histopathol 21:995-1027
29. Hoofnagle MH, Thomas JA, Wamhoff BR, Owens GK (2006) Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol 26:2579-2581
30. Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487-517
31. Mack CP (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:1495-1505
32. Challier JC, Kacemi A, Olive G (1995) Mixed culture of pericytes and endothelial cells from fetal microvessels of the human placenta. Cell Mol Biol 41:233-241
33. Helmbold P, Nayak RC, Marsch WC, Herman IM (2001) Isolation and in vitro characterization of human dermal microvascular pericytes. Microvasc Res 61:160-165
34. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
35. Hungerford JE, Little CD (1999) Developmental biology of the vascular smooth muscle cell. J Vasc Res 36:2-27
36. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767-801
37. Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, et al. (1997) Differentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 96:82-90
38. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, et al. (1996) Vascular remodelling. Hypertension 28(3):505-506
39. Helmbold P, Fiedler E, Fischer M, Marsch WCh (2004) Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol 31:431-440
40. Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM (1999) Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 42:930-941
41. Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, et al. (2008) Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One 3(1):e 14-52. doi: 10.1371/journal.pone.0001452
42. Witmer AN, van Blijswijk BC, van Noorden CJF, Vrensen GFJM, Schlingemann RO (2004) In vivo angiogenic phenotype of endothelial cells and pericyte induced by vascular endothelial growth factor-A. J Histochem Cytochem 52:39-52
43. Palumbo R, Gaetano C, Melillo G, Toschi E, Remuzzi A, et al. (2000) Shear stress downregulation of platelet-derived growth factor receptor-beta and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation 102:225-230
44. Newby AC (2006) Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69:614-624
45. Risinger GM Jr, Hunt TS, Updike DL, Bullen EC, Howard EW (2006) Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J Biol Chem 281:25915-25925
46. Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, et al. (2008) PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res 23:1519-1528
47. Varga J, Pasche B (2009) Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5(4):200-206
48. Hunzelmann N, Brinckmann J (2010) What are the new milestones in the pathogenesis of Systemic Sclerosis? Ann Rheum Dis 69:52-56
49. von Tell D, Armulik A, Betsholtz C (2006) Pericytes and vascular stability. Exp Cell Res 312(5):623-629
50. Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217(2):318-324
51. Rouwkema J, de Boer J, Van Blitterswijk CA (2006) Endothelial cells assemble into a 3-dimensional provascular network in a bone tissue engineering construct. Tissue Eng 12(9):2685-2693
52. Forte A, Della Corte A, De Feo M, Cerasuolo F, Cipollaro M (2010) Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm. Cardiovasc Res 88:395-405